Clinical Research Directory

Inclusion Criteria: * Clinical diagnosis of HCC * Patients who are scheduled to undergo therapy, either TACE systemic therapy or surgery 1. For TACE cohort, patients undergoing first cycle TACE are eligible. 2. For systemic therapy cohort, patients undergoing first-line systemic therapy are eligible. 3. For surgery cohort, patient undergoing surgery are eligible. * Prior surgery or loco-ablative therapy (e.g. Radiofrequency ablation, microwave, percutaneous ethanol injection) is allowed * Child's A to Child's C liver function Exclusion Criteria: * ECOG performance status \> 2 * Poorly controlled ascites